Tuesday, August 19, 2008 at 10:00 a.m. ET

SALT LAKE CITY, UT -- (Marketwire) -- 08/12/08 -- Myriad Genetics, Inc. (NASDAQ: MYGN) has arranged a conference call with the management team to provide a company update. Peter D. Meldrum, President and Chief Executive Officer, will host the call along with Jim Evans, Chief Financial Officer, Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., and Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

DATE: August 19, 2008
TIME: 10:00 am ET
DIAL-IN: 800 736 4594 or +1 212 231 2901
Reservation # 21390875
(Please dial in approximately 10 minutes before the call is scheduled to
begin)

A press release will be issued at 6:30 am ET on August 19, 2008.

Replay of the call will be available from two hours after the call for seven days by dialing (800) 633-8284 or (402) 977-9140, and entering reservation number 21390875.

A live audio Webcast will be available at: www.myriad.com